Document:

EX-10.11

 Exhibit 10.11 

Execution Version 
 PRIVATE
WARRANT AGREEMENT 
 Dated October 18, 2021 

THIS WARRANT AGREEMENT (this “Agreement”), dated October 18, 2021, is by and between Hoya Intermediate, LLC, a
Delaware limited liability company (the “Company”), Hoya Topco, LLC, a Delaware limited liability company (“Hoya Topco”) and any transferees of Hoya Topco permitted pursuant to this Agreement who
execute valid joinders hereto (Hoya Topco and such permitted transferees, the “Warrantholders”). 
 WHEREAS,
pursuant to that certain Transaction Agreement, dated as of April 21, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the “Transaction Agreement”) by and among the Company, Horizon
Sponsor, LLC, a Delaware limited liability company (“Sponsor”), Hoya Topco, Horizon Acquisition Corporation, a Cayman Islands exempted company, and Vivid Seats, Inc., a Delaware corporation (“VS PubCo”
and collectively with Hoya Topco and the Company, the “VS Entities”), among other things, the VS Entities agreed to consummate a Pre-Closing Restructuring (as defined in
the Transaction Agreement); 
 WHEREAS, pursuant to the Pre-Closing Restructuring, the Company
agreed to grant Hoya Topco warrants to purchase 3,000,000 common units of the Company (“Intermediate Common Units”) at an exercise price of $15.00 per unit (the “Warrants”); 

WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company and the Warrantholders; and 
 WHEREAS, all acts and things
have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations of the Company, and to authorize the
execution and delivery of this Agreement. 
 NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto
agree as follows: 
 1. Warrants. 
 1.1.
Form of Warrant. Each Warrant shall initially be issued in registered form only. 
 1.2. Effect of
Countersignature. If a physical certificate is issued, unless and until countersigned by the Company pursuant to this Agreement, a certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof. 

1.3. Registration. 

1.3.1. Warrant Register. The Company shall maintain books (the “Warrant Register”), for the registration of
original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants in book-entry form, the Company shall issue and register the Warrants in the names of the respective holders thereof in the denominations
issued to such holders. 
 If requested, the registered holder of a Warrant shall be issued a definitive certificate in physical form
evidencing such Warrants (“Definitive Warrant Certificates”) which shall be in the form annexed hereto as Exhibit A. Each Warrant shall bear the legend set forth in
Exhibit B. 
 Physical certificates, if issued, shall be signed by, or bear the facsimile signature of, the
Chairman of the Board, Chief Executive Officer, President, Chief Financial Officer, Chief Operating Officer, General Counsel, Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon
any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. 

 1.3.2. Registered Holder. Prior to due presentment for registration of transfer of
any Warrant, the Company may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby,
for the purpose of any exercise thereof, and for all other purposes, and the Company shall not be affected by any notice to the contrary. 

1.4. Fractional Warrants. The Company shall not issue fractional Warrants. 

2. Terms and Exercise of Warrants. 
 2.1.
Warrant Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of Intermediate Common Units stated therein, at the price
of $15.00 per unit, subject to the adjustments provided in Section 3 hereof and in the last sentence of this Section 2.1. The term “Warrant Price” as used in this Agreement
shall mean the price per unit (including in cash or by payment of Warrants pursuant to a “cashless exercise,” to the extent permitted hereunder) described in the prior sentence at which Intermediate Common Units may be purchased at the
time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than fifteen Business Days (unless otherwise required by the Commission,
any national securities exchange on which the Warrants are listed or applicable law); provided that the Company shall provide at least five days’ prior written notice of such reduction to Registered Holders of the Warrants; and provided
further, that any such reduction shall be identical among all of the Warrants. The term “Business Day” means a day, other than a Saturday, Sunday or federal holiday on which banks in New York City are generally open for
normal business. 
 2.2. Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise
Period”) (A) commencing on the date that is thirty (30) days after the date hereof and (B) terminating at 5:00 p.m., New York City time on the date that is ten (10) years after the date hereof (the
“Expiration Date”); provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 2.3.2 below, with
respect to an effective registration statement or a valid exemption therefrom being available; provided, further, that any Warrant may be classified by the Company upon the issuance of such Warrant, with the consent of the
Warrantholder, as an “Option Contingent Warrant” (it being understood that the Warrants granted to Hoya Topco on the date hereof shall consist of Option Contingent Warrants to purchase 1,000,000 Intermediate Common Units and other Warrants
to purchase 2,000,000 Intermediate Common Units), and any such Option Contingent Warrant shall be exercisable only to the extent, and following, the forfeiture or cancellation of an equivalent number of options to purchase shares of Class A
common stock of VS PubCo (“PubCo Common Stock”) which options are issued pursuant to the 2021 Vivid Seats Equity Incentive Plan within thirty (30) days of the date hereof with an exercise price equal to the Warrant Price
(or, if the fair market value of such shares of PubCo Common Stock is greater than the Warrant Price at the time of issuance, the fair market value of a share of PubCo Common Stock) (such options, the “Matching PubCo
Options”). For the avoidance of doubt, upon the forfeiture or cancellation of any Matching PubCo Option, an equivalent number of Option Contingent Warrants shall become exercisable pursuant to the terms hereof applicable to Warrants.
Each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in
its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided that the Company shall provide at least twenty (20) days prior written notice of any such extension to Registered Holders of the
Warrants and, provided further that any such extension shall be identical in duration among all the Warrants. 
 2.3. Exercise of
Warrants. 
 2.3.1. Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the
Registered Holder thereof by delivering to the Company (i) the Definitive Warrant Certificate evidencing the Warrants to be exercised, (ii) an election to purchase (“Election to Purchase”) any Intermediate Common
Units pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on 

  
 2 

 
the reverse of the Definitive Warrant Certificate, and (iii) the payment in full of the Warrant Price for each Intermediate Common Unit as to which the Warrant is exercised and any and all
applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Intermediate Common Units and the issuance of such Intermediate Common Units, as follows: 

(a) in lawful money of the United States, in good certified check or good bank draft payable to the order of the Company; or 

(b) with respect to any Warrant, by surrendering the Warrants for that number of Intermediate Common Units equal to the quotient obtained by
dividing (x) the product of the number of Intermediate Common Units underlying the Warrants, multiplied by the excess of the “Last Reported Sale Price” (as defined in this subsection 2.3.1(b))
less the Warrant Price by (y) the Last Reported Sale Price. The “Last Reported Sale Price” shall mean the last reported sale price of the Intermediate Common Units on the date prior to the date on which notice of
exercise of the Warrant is sent to the Company. 
 2.3.2. Issuance of Intermediate Common Units on Exercise. As soon as practicable
after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if payment is pursuant to subsection 2.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a book-entry
position or certificate, as applicable, for the number of Intermediate Common Units to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it on the register of members of the Company, and if such
Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of units as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be
obligated to deliver any Intermediate Common Units pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless (i) a registration statement under the Securities Act of 1933, as amended (the
“Securities Act”), with respect to the Intermediate Common Units underlying the Warrants is then effective and a prospectus relating thereto is current or (ii) a valid exemption from registration is available. No Warrant
shall be exercisable and the Company shall not be obligated to issue Intermediate Common Units upon exercise of a Warrant unless the Intermediate Common Units issuable upon such Warrant exercise have been registered, qualified or deemed to be exempt
from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. Subject to Section 3.6 of this Agreement, a Registered Holder of Warrants may exercise its
Warrants only for a whole number of Intermediate Common Units. If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional
interest in an Intermediate Common Unit, the Company shall round down to the nearest whole number, the number of Intermediate Common Units to be issued to such holder. For the avoidance of doubt, in no event will the Company be required to pay cash
to the holder of any Warrant. 
 2.3.3. Valid Issuance. All Intermediate Common Units issued upon the proper exercise of a Warrant in
conformity with this Agreement shall be validly issued, fully paid and nonassessable. 
 2.3.4. Date of Issuance. Each person in
whose name any book-entry position or certificate, as applicable, for Intermediate Common Units is issued and who is registered in the register of members of the Company shall for all purposes be deemed to have become the holder of record of such
Intermediate Common Units on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a
certificated Warrant, except that, if the date of such surrender and payment is a date when the register of members of the Company is closed, such person shall be deemed to have become the holder of such units at the close of business on the next
succeeding date on which the unit transfer books or book-entry system are open. 
 3. Adjustments. 

3.1. Equity Capitalizations. 

3.1.1. Sub-Divisions. If after the date hereof, and subject to the provisions of
Section 3.6 below, the number of issued and outstanding Intermediate Common Units is increased by a capitalization or unit dividend of Intermediate Common Units, or by a sub-division
of Intermediate Common Units or other similar event, then, on the effective date of such unit capitalization, sub-division or similar event, the number of Intermediate

  
 3 

 
Common Units issuable on exercise of each Warrant shall be increased in proportion to such increase in the issued and outstanding Intermediate Common Units. A rights offering made to all or
substantially all of the holders of Intermediate Common Units entitling holders to purchase Intermediate Common Units at a price less than the “Historical Fair Market Value” (as defined below) shall be deemed a capitalization of a number
of Intermediate Common Units equal to the product of (i) the number of Intermediate Common Units actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or
exercisable for the Intermediate Common Units) multiplied by (ii) one (1) minus the quotient of (x) the price per Intermediate Common Unit paid in such rights offering divided by (y) the Historical Fair Market Value. For purposes
of this subsection 3.1.1, (i) if the rights offering is for securities convertible into or exercisable for Intermediate Common Units, in determining the price payable for Intermediate Common Units, there shall be taken
into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) ”Historical Fair Market Value” means the volume weighted average price of PubCo
Common Stock during the ten (10) trading day period ending on the trading day prior to the first date on which the PubCo Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such
rights. 
 3.1.2. Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, pays to all
or substantially all of the holders of the Intermediate Common Units a dividend or makes a distribution in cash, securities or other assets on account of such Intermediate Common Units (or other units into which the Warrants are convertible), other
than (a) as described in subsection 3.1.1 above, (b) Ordinary Cash Dividends (as defined below) or (c) as a result of any redemption rights under the Second Amended and Restated Limited Liability Agreement of
the Company, dated as of the date hereof (as amended, modified or restated from time to time, the “Company LLC Agreement”) (any such non-excluded event being referred to herein as an
“Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by the
Company’s board of managers (the “Board”), in good faith) of any securities or other assets paid on each Intermediate Common Unit in respect of such Extraordinary Dividend. For purposes of this
subsection 3.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per unit basis, with the per unit amounts of all other cash dividends and cash
distributions paid on the Intermediate Common Units during the 365-day period ending on the date of declaration of such dividend or distribution to the extent it does not exceed $0.50 (which amount shall be
adjusted to appropriately reflect any of the events referred to in other subsections of this Section 3 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the
number of Intermediate Common Units issuable on exercise of each Warrant). 
 3.2. Aggregation of Units. If after the date hereof,
and subject to the provisions of Section 3.6 hereof, the number of issued and outstanding Intermediate Common Units is decreased by a consolidation, combination, reverse unit
sub-division or reclassification of Intermediate Common Units or other similar event, then, on the effective date of such consolidation, combination, reverse unit
sub-division, reclassification or similar event, the number of Intermediate Common Units issuable on exercise of each Warrant shall be decreased in proportion to such decrease in issued and outstanding
Intermediate Common Units. 
 3.3. Adjustments in Exercise Price. Whenever the number of Intermediate Common Units purchasable upon
the exercise of the Warrants is adjusted, as provided in subsection 3.1.1 or Section 3.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price
immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of Intermediate Common Units purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of
which shall be the number of Intermediate Common Units so purchasable immediately thereafter. 
 3.4. Replacement of Securities upon
Reorganization, etc. In case of any reclassification or reorganization of the issued and outstanding Intermediate Common Units (other than pursuant to a change covered by Section 3.1 or
Section 3.2 hereof or that solely affects the par value of such Intermediate Common Units), or in the case of any merger or consolidation of the Company with or into another entity (other than a consolidation or merger in
which the Company is the continuing entity and that does not result in any reclassification or reorganization of the issued and outstanding Intermediate Common Units), or in the case of any sale or conveyance to another corporation or entity of the
assets or other property of the Company as an entirety or substantially as an 

  
 4 

 
entirety, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the
Intermediate Common Units of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of units or stock or other securities or property (including cash) receivable upon
such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s) immediately prior
to such event (the “Alternative Issuance”); provided, however, that if the holders of the Intermediate Common Units were entitled (including pursuant to the terms of the Company LLC Agreement) to exercise a right of election
as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative Issuance for which each Warrant shall become
exercisable shall be deemed to be the weighted average of the kind and amount received per unit by the holders of the Intermediate Common Units in such consolidation or merger that affirmatively make such election; provided further
that if less than 70% of the consideration receivable by the holders of the Intermediate Common Units in the applicable event is payable in the form of equity in the successor entity that is listed for trading on a national securities exchange or is
quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder properly
exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by VS PubCo pursuant to a Current Report on Form 8-K filed with the Commission,
the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero)
minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes
Warrant Model for an Uncapped American Call on Bloomberg Financial Markets (assuming zero dividends) (“Bloomberg”). For purposes of calculating such amount, (i) the price of each Intermediate Common Unit shall be the
volume weighted average price of the PubCo Common Stock during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (ii) the assumed volatility shall be the 90 day volatility
obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event and (iii) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a
period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the Intermediate Common Units consists exclusively of cash, the amount of such cash per
Intermediate Common Unit, and (ii) in all other cases, the volume weighted average price of the PubCo Common Stock during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any
reclassification or reorganization also results in a change in Intermediate Common Units covered by subsection 3.1.1, then such adjustment shall be made pursuant to subsection 3.1.1 or
Sections 3.2, 3.3 and this Section 3.4. The provisions of this Section 3.4 shall similarly apply to successive reclassifications, reorganizations, mergers or
consolidations, sales or other transfers. In no event shall the Warrant Price be reduced to less than the par value per unit issuable upon exercise of such Warrant. 

3.5. Notices of Changes in Warrant. Upon the occurrence of any event specified in Sections 3.1, 3.2,
3.3, or 3.4, the Company shall give written notice of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the
event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event. 
 3.6. No Fractional
Units. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional units upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this
Section 3, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a unit, the Company shall, upon such exercise, round down to the nearest whole number the number
of Intermediate Common Units to be issued to such holder. 
 3.7. Form of Warrant. The form of Warrant need not be
changed because of any adjustment pursuant to this Section 3, and Warrants issued after such adjustment may state the same Warrant Price and the same number of units as is stated in the Warrants initially issued pursuant to
this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant
thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed. 

  
 5 

 4. Transfer and Exchange of Warrants. 

4.1. Registration of Transfer. The Company shall register the proper transfer pursuant to this Section 4,
from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such
transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Company. 

4.2. Procedure for Surrender of Warrants. Warrants may be surrendered to the Company, together with a written request for exchange or
transfer, and thereupon the Company shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided further,
however that in the event that a Warrant surrendered for transfer bears a restrictive legend, the Company shall not cancel such Warrant and issue new Warrants in exchange thereof until the Company has received an opinion of counsel for the
Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend. 
 4.3.
Fractional Warrants. The Company shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a warrant certificate or book-entry position for a fraction of a Warrant. 

4.4. Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants. 

4.5. Transfer Restrictions. Each Warrant shall be transferrable only (i) to the extent the Intermediate Common Unit underlying
such Warrant would be transferable pursuant to the terms of the Company LLC Agreement, (ii) the transferring Warrantholder and the transferee comply with the applicable requirements of Article VIII of the Company LLC Agreement and
(iii) the transferee executes a valid joinder to this Agreement in a form reasonably acceptable to the Company. 
 5. Other Provisions Relating to
Rights of Holders of Warrants. 
 5.1. No Rights as Unitholder. A Warrant does not entitle the Registered Holder thereof to any
of the rights of a unitholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as unitholders in respect of the meetings
of unitholders or the election of managers of the Company or any other matter, or any rights under the Company LLC Agreement. 
 5.2.
Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company may on such terms as to indemnity or otherwise as it may in its discretion impose (which shall, in the case of a mutilated
Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company,
whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone. 
 5.3.
Reservation of Intermediate Common Units. The Company shall at all times reserve and keep available a number of its authorized but unissued Intermediate Common Units that shall be sufficient to permit the exercise in full of all outstanding
Warrants issued pursuant to this Agreement. 
 6. Miscellaneous Provisions. 

6.1. Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrantholders shall
bind and inure to the benefit of their respective successors and assigns. 
 6.2. Notices. Any notice, statement or demand authorized
by this Agreement to be given or made by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered (i) by electronic mail, (ii) by hand or overnight delivery or (ii) if sent by certified mail or
private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrantholder(s)), as follows: 

  
 6 

 Hoya Intermediate, LLC 

111 N. Canal Street, Suite 800 

Chicago, IL 60606 
 Attention:
General Counsel 
 Email: legal@vividseats.com 

with a copy to: 

Latham & Watkins LLP 

330 North Wabash Avenue, Suite 2800 

Chicago, IL 60611 

	 	Attention:	 Bradley Faris 

Owen Alexander 

	 	Email:	 Bradley.faris@lw.com 

Owen.alexander@lw.com 
 6.3.
Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York. Subject to applicable law, the Company hereby
agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New
York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an
inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United
States of America are the sole and exclusive forum. 
 Any person or entity purchasing or otherwise acquiring any interest in the Warrants
shall be deemed to have notice of and to have consented to the forum provisions in this Section 6.3. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than
a court located within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to:
(x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the
forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as agent for such
warrant holder. 
 6.4. Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or
give to, any person, corporation or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or
agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the
Warrants. 
 6.5. Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such
counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

6.6. Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not
affect the interpretation thereof. 

  
 7 

 6.7. Amendments. This Agreement may be amended by the Company without the consent of
any Warrantholder for the purpose of (i) curing any ambiguity or to correct any mistake or defective provision contained herein, (ii) amending the definition of “Ordinary Cash Dividend” as contemplated by and in accordance with
the second sentence of subsection 3.1.2 or (iii) adding or changing any provisions with respect to matters or questions arising under this Agreement as the Company may reasonably deem necessary or desirable and that
the Company reasonably deem shall not adversely affect the rights of the Registered Holders under this Agreement. All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise
Period, shall require the vote or written consent of the Registered Holders of 65% of the then-outstanding Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to
Sections 2.1 and 2.2, respectively, without the consent of the Registered Holders. 
 6.8.
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof.
Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be
possible and be valid and enforceable. 
 Exhibit A Form of Warrant Certificate 

Exhibit B Legend —Warrants 

[Signature Page Follows] 

  
 8 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first above written. 
  

			
	HOYA INTERMEDIATE, LLC
		
	By:	 	/s/ Stanley Chia
		 	Name: Stanley Chia
		 	Title: Chief Executive Officer
	
	HOYA TOPCO, LLC
		
	By:	 	/s/ Stanley Chia
		 	Name: Stanley Chia
		 	Title: Chief Executive Officer

 [Signature Page to Hoya Intermediate, LLC $15.00 Warrant Agreement] 

 ANNEX A 

[FACE] 
 Number 

Warrants 
 THIS WARRANT
SHALL BE VOID IF NOT EXERCISED PRIOR TO 
 THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR 

IN THE WARRANT AGREEMENT DESCRIBED BELOW 

Hoya Intermediate, LLC 

Formed Under the Laws of Delaware 

CUSIP [●] 
 Warrant
Certificate 
 This Warrant Certificate certifies that [        ], or registered
assigns, is the registered holder of [        ] warrant(s) (the “Warrants” and each, a “Warrant”) to purchase common units (“Intermediate Common
Units”), of Hoya Intermediate, LLC, a Delaware limited liability company (the “Company”). Each Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to below, to
receive from the Company that number of fully paid and nonassessable Intermediate Common Units as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in
lawful money (or through “cashless exercise” as provided for in the Warrant Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the corporate office of
the Company referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement. 

Each whole Warrant is initially exercisable for one fully paid and non-assessable Intermediate Common
Unit. Fractional units shall not be issued upon exercise of any Warrant. The number of Intermediate Common Units issuable upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events as set forth in the Warrant
Agreement. [This Warrant is a “Option Contingent Warrant” and shall be subject to the terms thereof set forth in the Warrant Agreement.] 

The initial Exercise Price per one Intermediate Common Unit for any Warrant is equal to $15.00 per unit. The Exercise Price is subject to
adjustment upon the occurrence of certain events as set forth in the Warrant Agreement. 
 Subject to the conditions set forth in the
Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such Warrants shall become void. The Warrants are not subject to redemption by the Company. 

Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions
shall for all purposes have the same effect as though fully set forth at this place. 
 This Warrant Certificate shall not be valid unless
signed by the Company. This Warrant Certificate shall be governed by and construed in accordance with the internal laws of the State of New York. 

 
			
	HOYA INTERMEDIATE, LLC
		
	By:	 	 
		 	Name:
		 	Title: Authorized Signatory

 [Form of Warrant Certificate] 

[Reverse] 
 The Warrants
evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive [        ] Intermediate Common Units and are issued or to be issued pursuant to
a Warrant Agreement dated as of October 18, 2021 (the “Warrant Agreement”), by and between the Company and the holders of the Warrants, which Warrant Agreement is hereby incorporated by reference in and made a part of
this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Company and the holders (the words “holders” or
“holder” meaning the Registered Holders or Registered Holder, respectively) of the Warrants. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant
Agreement. 
 Warrants may be exercised at any time during the Exercise Period set forth in the Warrant Agreement, subject to the conditions
applicable to exercise set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering this Warrant Certificate, with the form of Election to Purchase set forth hereon properly
completed and executed, together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant Agreement) at the principal corporate office of the Company. In
the event that upon any exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant
Certificate evidencing the number of Warrants not exercised. 
 Notwithstanding anything else in this Warrant Certificate or the Warrant
Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the issuance of the Intermediate Common Units to be issued upon exercise is effective under the Securities Act and (ii) a
prospectus thereunder relating to the Intermediate Common Units is current, except through “cashless exercise” as provided for in the Warrant Agreement. 

The Warrant Agreement provides that upon the occurrence of certain events the number of Intermediate Common Units issuable upon exercise of
the Warrants set forth on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in an Intermediate Common Unit, the Company shall, upon
exercise, round down to the nearest whole number of Intermediate Common Units to be issued to the holder of the Warrant. 
 Warrant
Certificates, when surrendered at the corporate office of the Company by the Registered Holder thereof in person or by legal representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations
provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants. 

Upon due presentation for registration of transfer of this Warrant Certificate at the corporate office of the Company a new Warrant
Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant
Agreement, without charge except for any tax or other governmental charge imposed in connection therewith. 
 The Company may deem and treat
the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the
holder(s) hereof, and for all other purposes, and the Company shall not be affected by any notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a unitholder of the Company. 

 Election to Purchase 

(To Be Executed Upon Exercise of Warrant) 

The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive
[        ] Intermediate Common Units and herewith tenders payment for such Intermediate Common Units to the order of Hoya Intermediate, LLC (the “Company”) in the amount of
$[        ] in accordance with the terms hereof. The undersigned requests that a certificate for such Intermediate Common Units be registered in the name of [        ],
whose address is [        ] and that such Intermediate Common Units be delivered to [        ] whose address is [        ]. If
said [        ] number of Intermediate Common Units is less than all of the Intermediate Common Units purchasable hereunder, the undersigned requests that a new Warrant Certificate representing the remaining
balance of such Intermediate Common Units be registered in the name of [        ], whose address is [        ] and that such Warrant Certificate be delivered to
[        ], whose address is [        ]. 
 In the event
that the Warrant is a Private Placement Warrant that is to be exercised on a “cashless” basis pursuant to subsection 2.3.1(b) of the Warrant Agreement, the number of Intermediate Common Units that this
Warrant is exercisable for shall be determined in accordance with subsection 2.3.1(b) of the Warrant Agreement. 

In the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number
of Intermediate Common Units that this Warrant is exercisable for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise and (ii) the holder hereof shall complete the
following: The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive Intermediate Common Units. If said number of units is
less than all of the Intermediate Common Units purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such Intermediate Common Units be
registered in the name of [        ], whose address is [        ] and that such Warrant Certificate be delivered to [        ],
whose address is [        ]. 
 [Signature Page Follows] 

 Date: [        ] 

 

	
	(Signature)
	(Address)
	   

	(Tax Identification Number)

 Signature Guaranteed: 
  

	
	   

 THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS
AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED). 

 EXHIBIT B 

LEGEND 
 THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE LIMITED LIABILITY COMPANY
AGREEMENT OF HOYA INTERMEDIATE, LLC (THE “COMPANY”), AS AMENDED FROM TIME TO TIME. 
 NO.
[        ] WARRANTExhibit 10.3

 

EXECUTIVE EMPLOYMENT AGREEMENT

 

This Executive
Employment Agreement (this “Agreement”) is made and entered into as of September [ ], 2021 by and
between Journey Medical Corporation (the “Company”) and
Ernest De Paolantonio (“Executive”). The Company and Executive are hereinafter collectively referred to as the
 “Parties”, and individually referred to as a “Party”.

 

Recitals

 

WHEREAS the Company desires
to employ Executive and Executive desires to accept employment, on the terms and conditions set forth in this Agreement;

 

WHEREAS, in his position,
Executive will have access to confidential information concerning the Company’s business, its customers and employees; and

 

WHEREAS, the Company wishes
to protect itself from unauthorized use of this information and to protect its investment in its employees, customer relationships and
confidential information.

 

NOW, THEREFORE, in consideration
of the foregoing, the mutual agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Parties agree as follows:

 

Agreement

 

		1.	Employment.

 

1.1              Term.
This Agreement will take effect on October 1, 2021 (the “Effective Date”) and will continue in effect until
it is terminated pursuant to Section 4 herein.

 

1.2            Title.
Effective as of the Effective Date, Executive is employed by the Company in the position of Chief Financial Officer. Executive will
report to the Company’s Chief Executive Officer.

 

1.3              Duties.
Executive will do and perform all services, acts or things necessary or advisable to conduct the business of the Company and that
are normally associated with the position of Chief Financial Officer. Executive’s duties will also include such other duties as
the Company may direct from time to time. Executive will devote his full business time, attention, knowledge and skills to the affairs
of the Company and to his duties hereunder and will perform such duties diligently and to the best of his ability, in compliance with
the Company’s policies and procedures and the laws and regulations that apply to the Company’s business.

 

1.4              Location. Unless the Parties otherwise agree in writing, Executive will work remotely. Notwithstanding the foregoing, Executive
understands and agrees that the Company may from time to time require Executive to travel temporarily to other locations in connection
with the Company’s business, including but not limited to the Company’s headquarters in Scottsdale, Arizona.

 

    1 

     

    

 

		2.	Restrictive Covenants.

 

2.1                Agreements
Protecting Confidential and Proprietary Information. In connection with and as a material condition of the Company’s employment
of Executive, Executive understands, acknowledges and agrees to promptly execute and be bound by certain restrictive covenants during
and after his employment with the Company, as contained in the Company’s Proprietary Information and Inventions Agreement (“PIIA”).
A copy of the PIIA is attached to this Agreement as Exhibit A. Executive acknowledges and agrees that his services to the Company
pursuant to this Agreement are unique and extraordinary and that in the course of performing such services Executive will have access
to and knowledge of significant confidential, proprietary, and trade secret information belonging to the Company. Executive agrees that
the provisions and restrictions set forth in the PIIA are reasonable and necessary to protect the Company’s legitimate business
interests in its goodwill, its confidential, proprietary, and trade secret information, and its investment in the unique and extraordinary
services to be provided by Executive pursuant to this Agreement.

 

2.2               
Non-Competition and Non-Solicitation.

 

2.2.1       
Purpose. Executive understands and agrees that the purpose of this Section 2.2 is to protect the Company’s legitimate
business interests, including, but not limited to its confidential and proprietary information, customer relationships and goodwill, and
the Company’s competitive advantage, and will not unreasonably impair Executive’s ability or right to work or earn a living.
Therefore, Executive agrees to be subject to restrictive covenants under the following terms.

 

2.2.2       
Definitions. As used in this Agreement, the following terms have the meanings given to such terms below.

 

(i)           “Business”
means the business(es) in which the Company is or was engaged at the time of, or during the 12-month period prior to, the termination
of Executive’s employment with the Company for any reason.

 

(ii)         “Customer”
means any person or entity who is or was a customer or client of the Company at the time of, or during the 12-month period prior to,
the termination of Executive’s employment with the Company for any reason.

 

(iii)        “Company Employee” means any person who is or was an employee of the Company at the time of, or during the
12-month period prior to, the termination of Executive’s employment with the Company for any reason.

 

(iv)         “Restricted
Period” means the period commencing on the date of termination of Executive’s employment with the Company for any reason
and ending 12 months after such date; provided, however, that the period will be tolled and will not run during any time Executive is
in violation of this Section 2.2, it being the intent of the parties that the Restricted Period will be extended for any period of time
in which Executive is in violation of this Section 2.2.

 

    2 

     

    

 

(v)           “Territory”
means the United States of America, it being understood that the Company’s business is nationwide in scope and a nationwide restriction
is reasonable and necessary to protect the Company’s interests.

 

2.2.3       Non-Participation
with the Company’s Competitors. During his employment with the Company, Executive will not, on his own behalf or on behalf
of any other person, engage in any business competitive with or adverse to that of the Company. In addition, during his employment with
the Company, Executive will not acquire, assume or participate in, directly or indirectly, any position, investment or interest known
by Executive to be adverse or antagonistic to the Company, its business, or prospects, financial or otherwise, or in any company, person,
or entity that is, directly or indirectly, in competition with the business of the Company or any of its affiliates. Ownership by Executive,
in professionally managed funds over which the Executive does not have control or discretion in investment decisions, or as a passive
investment, of less than 2% of the outstanding shares of capital stock of any corporation with one or more classes of its capital stock
listed on a national securities exchange or publicly traded on a national securities exchange or in the over-the-counter market will
not constitute a breach of this Section 2.2.3.

 

2.2.4      Non-Competition.
During his employment with the Company and during the Restricted Period, Executive will not, directly or indirectly, (i) engage in
the Business in the Territory (other than on behalf of the Company), or (ii) hold a position based in or with responsibility for all
or part of the Territory, with any person or entity engaging in the Business, whether as an employee, consultant, or otherwise, in which
Executive will have duties, or will perform or be expected to perform services for such person or entity, that is or are the same as
or substantially similar to the position held by Executive or those duties or services actually performed by Executive for the Company
within the 12-month period immediately preceding the termination of Executive’s employment with the Company, or in which Executive
will use or disclose or be reasonably expected to use or disclose any confidential or proprietary information of the Company for the
purpose of providing, or attempting to provide, such person or entity with a competitive advantage with respect to the Business.

 

2.2.5       Non-Solicitation.
During his employment with the Company and during the Restricted Period, Executive will not, directly or indirectly, on Executive’s
own behalf or on behalf of any other party (except on behalf of the Company):

 

		(i)	Call upon, solicit, divert, encourage or attempt to call upon, solicit, divert, or encourage any Customer
for purposes of marketing, selling, or providing products or services to such Customer that are competitive with those offered by the
Company;

 

		(ii)	Accept as a customer any Customer for purposes of marketing, selling, or providing products or services
to such Customer that are competitive with those offered by the Company;

 

		(iii)	Induce, encourage, or attempt to induce or encourage any Customer to reduce, limit, or cancel its business
with the Company;

 

    3 

     

    

 

		(iv)	Solicit, induce, or attempt to solicit or induce any Company Employee to terminate his or her employment
with the Company; or

 

		(v)	Otherwise interfere with or engage in any conduct that would have the effect of interfering with the business
relationship between the Company and any of its vendors, suppliers, consultants, or contractors.

 

2.2.6       
Reasonableness of Restrictions. Executive acknowledges and agrees that (i) his services to the Company under this Agreement
are unique and extraordinary; (ii) the restrictive covenants in this Agreement are essential elements of Executive’s employment
by the Company and are reasonable given Executive’s access to the Company’s confidential information and the substantial knowledge
and goodwill Executive will acquire with respect to the business of the Company as a result of his employment with the Company, and the
unique and extraordinary services to be provided by Executive to the Company; (iii) the restrictive covenants contained in this Agreement
are reasonable in time, territory, and scope, and in all other respects; and (iv) enforcement of the restrictions contained herein will
not deprive the Executive of the ability to earn a reasonable living.

 

2.2.7       
Judicial Modification. Should any part or provision of this Section 2.2 be held invalid, void, or unenforceable in any court
of competent jurisdiction, such invalidity, voidness, or unenforceability will not render invalid, void, or unenforceable any other part
or provision of this Agreement. The parties further agree that if any portion of this Section 2.2 is found to be invalid or unenforceable
by a court of competent jurisdiction because its duration, territory, or other restrictions are deemed to be invalid or unreasonable in
scope, the invalid or unreasonable terms will be replaced by terms that are valid and enforceable and that come closest to expressing
the intention of such invalid or unenforceable terms.

 

2.2.8       
Enforcement. Executive acknowledges and agrees that the Company will suffer irreparable harm in the event that Executive breaches
any of Executive’s obligations under this Section 2.2 and that monetary damages would be inadequate to compensate the Company for
such breach. Accordingly, Executive agrees that, in the event of a breach by Executive of any of Executive’s obligations under this
Section 2.2, the Company will be entitled to obtain from any court of competent jurisdiction preliminary and permanent injunctive relief,
in order to prevent or to restrain any such breach. Executive agrees to waive any requirement for the securing or posting of any bond
in connection with such remedies. The Company will be entitled to recover its costs incurred in connection with enforcing this Section
2.2, including reasonable attorneys’ fees and expenses.

 

		3.	Compensation
                                            of Executive.

 

3.1                  Base
Salary. The Company will pay Executive a base salary at the annualized rate of Three Hundred Thousand
Dollars ($300,000.00) (the “Base Salary”), to be paid in equal installments in accordance with the
Company’s normal payroll practices. The Base Salary will be prorated for any partial year of employment on the basis of a
365-day fiscal year and may be increased in the discretion of the Company. The Base Salary may only be decreased in connection with
a Company-wide decrease in compensation to similarly-situated executive employees of the Company; provided, however that Executive
will not be subject to any greater percentage reduction than any other similarly-situated Company executive.

 

    4 

     

    

 

3.2                   
Sign on Bonus. Executive will receive a $50,000 sign on bonus, payable in two equal installments, as follows: (i) $25,000 will
be payable on the first payroll processing date following the three-month anniversary of Executive’s start date (the “First
Installment Date”); and (ii) $25,000 will be payable on the first payroll processing date following the six-month anniversary
of the Executive’s start date (the “Second Installment Date”). Executive must remain employed by the Company
through each applicable payment date in order to earn and receive the corresponding bonus payment. If Executive is not employed by the
Company through the First Installment Date, no pro rata sign on bonus will be payable or received. If Executive is employed by
the Company through the First Installment Date but not through the Second Installment Date, no pro rata portion of the second installment
of the sign on bonus will be payable or received. If Executive’s employment with the Company ends, except by reason of a termination
by the Company without Cause (as defined below) or Executive’s resignation for Good Reason (as defined below), at any time prior
to the one-year anniversary of Executive’s start date, then Executive will be required to repay to the Company a prorated portion
of the sign on bonus (determined based on the number of months completed since the Effective Date) within 15 days following the end of
Executive’s employment.

 

3.3                   
Annual Bonus Compensation. Executive will be eligible to receive an annual bonus targeted at 30% of his Base Salary based upon
the Company’s performance and his individual performance on behalf of the Company during the preceding calendar year. Whether to
award a bonus for any calendar year, and if so, in what amount, will be determined by the Company in its discretion. Executive must remain
employed by the Company through the bonus payment date in order to earn or receive any discretionary annual bonus. No pro rata bonus
will be earned or payable for partial years of employment.

 

3.4                     
Equity Grant. Subject to approval by the Company’s Board of Directors (the “Board”), Executive
will be granted an equity grant of 120,000 shares of the Company’s common stock (the “Equity Grant”) in
the form of restricted stock, restricted stock units, or options as determined by the Board. One third of the equity award will vest on
each of the first, second, and third anniversaries of the grant date subject to Executive’s continuing employment and eligibility
on each vesting date. The Equity Grant will be governed by the terms of the Company’s 2014 Stock Plan, as amended from time to time,
and a related equity grant agreement to be entered between Executive and the Company. Executive will also be eligible to receive additional
equity awards as determined by the Board in its discretion, based upon the Company’s performance and his individual performance
on behalf of the Company, and such other factors as the Board may determine.

 

3.5                  
Expense Reimbursements. The Company will reimburse Executive for all reasonable business expenses incurred by Executive in
connection with the performance of his duties hereunder, subject to the Company’s reimbursement policies in effect from time to
time.

 

3.6                   Benefits.
Executive will be entitled to such other benefits, and to participate in such benefit plans, as are generally made available to
similarly situated senior executive employees of the Company from time to time, subject to Company policy and the terms and
conditions of any applicable benefit plans. Nothing in this Agreement will be deemed to alter the Company’s rights to modify
or terminate any such plans or programs in its sole discretion.

 

    5 

     

    

 

3.7                   
Holidays and Vacation. Executive will be eligible to accrue up to four weeks of paid vacation per year and will receive paid
Company holidays in accordance with Company policy. All available time off must be used in accord with the Company’s policies and
procedures. To the extent Executive would be entitled to a greater number of vacation days under any other Company policy, such other
policy will govern.

 

3.8                   
Withholdings. The Company may withhold from any amounts payable under this Agreement such federal, state and local taxes as
the Company determines are required to be withheld pursuant to any applicable law or other amount properly requested by Executive.

 

		4.	Termination.

 

4.1                   Termination
by the Company. Executive’s employment with the Company is at will and may be terminated by the Company at any time and for
any reason, or for no reason, including, but not limited to, under the following conditions:

 

4.1.1       
Termination by the Company for Cause. The Company may terminate Executive’s employment for “Cause” (as defined
below) by delivery of written notice to Executive in accordance with the definition and procedures set forth in Section 4.6.2 below. Any
notice of termination given pursuant to this Section 4.1.1 will effect termination as of the date of the notice or as of such other date
as specified in the notice, subject to Section 4.6.2.

 

4.1.2       
Termination by the Company without Cause. The Company may terminate Executive’s employment without Cause at any time
and for any reason or for no reason. Such termination will be effective on the date Executive is so informed or as otherwise specified
by the Company.

 

4.2                   Termination
by Resignation of Executive. Executive’s employment with the Company is at will and may be terminated by Executive at any time
and for any reason or for no reason, including via a resignation for Good Reason in accordance with the Good Reason Process set forth
in Section 4.6.3 below.

 

4.3                   Termination
for Death or Complete Disability. Executive’s employment with the Company will terminate effective upon the date of Executive’s
death or upon notice by the Company as a result of Executive’s Complete Disability (as defined below); provided, however, nothing
herein will give the Company the right to terminate Executive prior to discharging its obligations to Executive, if any, under the Family
and Medical Leave Act, the Americans with Disabilities Act, or any other applicable law.

 

4.4                   Termination
by Mutual Agreement of the Parties. Executive’s employment with the Company may be terminated at any time upon a mutual agreement
in writing of the Parties. Any such termination of employment will have the consequences specified in such agreement.

 

    6 

     

    

 

4.5                   
Compensation Upon Termination. 

 

4.5.1       
 Generally. When Executive’s employment is terminated for any reason, Executive, or his estate, as the case may be, will
be entitled to receive the compensation and benefits earned through the effective date of termination, including, but not limited to,
as applicable, any Base Salary earned by Executive through the date of termination, expenses subject to reimbursement pursuant to Company
policy incurred by Executive through the date of termination, and accrued and unused vacation benefits earned through the date of termination
at the rate in effect at the time of termination.

 

4.5.2       
Termination Without Cause or Resignation For Good Reason. If the Company terminates Executive’s employment without Cause
or if Executive resigns for Good Reason, then, in addition to the amounts described in Section 4.5.1, and conditioned upon Executive executing
and not revoking a release of claims in a form acceptable to the Company (the “Release”) within the time periods
specified therein, the Company will provide Executive with the following separation benefits (together, the “Separation Benefits”):
(i) the Company will pay Executive severance in an amount equal to six months of Executive’s Base Salary (at the rate in effect
as of the termination); and (ii) if Executive timely elects continued health insurance coverage under COBRA, the Company will pay the
entire premium necessary to continue such coverage for Executive and Executive’s eligible dependents for a period of six months
or, if earlier, when Executive becomes eligible for group health insurance coverage under another employer’s plan, provided, however,
that the Company will have the right to terminate such payment of COBRA premiums on behalf of Executive and instead pay Executive a lump
sum amount equal to the COBRA premium times the number of months remaining in the specified period if the Company determines in its discretion
that continued payment of the COBRA premiums is or may be discriminatory under Section 105(h) of the Internal Revenue Code. The severance
payments under clause (i) above will be payable to Executive over time in accordance with the Company’s payroll practices and procedures
beginning on the 60th day following the termination of Executive’s employment with the Company, provided that the first installment
will include all installments that would have been paid if the payments had commenced immediately following the date of termination. Notwithstanding
the foregoing, if Executive is entitled to receive the Separation Benefits but violates any provisions of Section 2 hereof or the PIIA,
the Company will be entitled to immediately stop paying any further installments of the Separation Benefits, in addition to any other
remedies that may be available to the Company in law or at equity.

 

4.5.3       
No Further Obligations. Except as expressly provided above or as otherwise required by law, the Company will have no obligations
to Executive in the event of the termination of this Agreement for any reason.

 

4.6                   
Definitions. For purposes of this Agreement, the following terms will have the following meanings:

 

4.6.1        Complete
Disability. As used herein, “Complete Disability” means the inability of Executive, due to the
condition of his physical, mental or emotional health, effectively to perform the essential functions of his job with or without
reasonable accommodation for a continuous period of more than 90 days or for 90 days in any period of 180 consecutive days. In the
event that a question should arise as to whether a Complete Disability exists, then for purposes of making such a determination, at
the Company’s request Executive agrees to make himself available and to cooperate in a reasonable examination by a licensed
independent physician retained by the Company and to authorize the disclosure and release to the Company of all medical records
related to such examination.

 

    7 

     

    

 

4.6.2       
Cause. As used herein, “Cause” means: (i) Executive’s fraud, embezzlement or misappropriation
with respect to the Company; (ii) Executive’s material breach of this Agreement; (iii) Executive’s material breach of the
PIIA; (iv) Executive’s breach of fiduciary duties to the Company; (v) Executive’s willful failure or refusal to perform his
material duties under this Agreement or failure to follow any specific lawful instructions of the Company’s Chief Executive Officer;
(vi) Executive’s conviction or plea of nolo contendere in respect of a felony or of a misdemeanor involving moral turpitude; (vii)
Executive’s willful or negligent act or omission that has or may reasonably be expected to have a material adverse effect on the
property, business, or reputation of the Company; (viii) Executive’s material failure to comply with the Company’s workplace
rules, policies, or procedures; or (ix) Executive’s failure to cooperate with a bona fide internal investigation or an investigation
by regulatory or law enforcement authorities, after being instructed by the Company to cooperate, or the willful destruction or failure
to preserve documents or other materials known to be relevant to such investigation or the inducement of others to fail to cooperate or
to produce documents or other materials in connection with such investigation. In the event that the Company concludes that Executive
has engaged in acts constituting in Cause as defined in clause (ii) or (v) above, prior to terminating this Agreement for Cause the Company
will provide Executive with at least 10 days’ notice of the circumstances constituting such Cause and an opportunity to correct
such circumstances, to the extent such circumstances are susceptible of being corrected.

 

4.6.3       
Good Reason. Executive may resign for Good Reason by complying with the Good Reason Process. As used in this Agreement, “Good
Reason Process” means that (i) Executive reasonably determines in good faith that a “Good Reason” condition
has occurred; (ii) Executive notifies the Company in writing of the first occurrence of the Good Reason condition within 30 days of the
first occurrence of such condition; (iii) Executive cooperates in good faith with the Company’s efforts, for a period of 30 days
following such notice (the “Good Reason Cure Period”), to remedy the condition; (iv) notwithstanding such efforts,
the Good Reason condition continues to exist; and (v) Executive terminates Executive’s employment within 30 days after the end of
the Good Reason Cure Period. If the Company cures the Good Reason condition during the Good Reason Cure Period, Good Reason shall be deemed
not to have occurred with respect to the particular circumstances claimed to have constituted Good Reason. For purposes of this Agreement,
 “Good Reason” means the occurrence of any of the following events without Executive’s consent: (x) a material
reduction of Executive’s Base Salary, except in connection with a Company-wide decrease in executive compensation as provided in
Section 3.1 of this Agreement, (y) a material diminution of Executive’s authority, duties, or responsibilities, or (z) the Company’s
material breach of this Agreement.

 

4.7                   
Survival of Certain Sections. Sections 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, and 17 of this Agreement will survive the
termination of this Agreement.

 

    8 

     

    

 

4.8                    Section
409A Compliance. The Parties intend that all provisions of this Agreement and the payments made pursuant thereto will comply
with, or be exempt from, the application of Section 409A of the Internal Revenue Code of 1986 as amended and the regulations and
other guidance thereunder and any state law of similar effect (collectively “Section 409A”), and all
provisions of this Agreement will be construed, to the maximum extent possible, in a manner consistent with the requirements for
avoiding taxes or penalties under Section 409A. Notwithstanding anything to the contrary set forth herein, any payments and benefits
provided under this Section 4 that constitute “deferred compensation” within the meaning of Section 409A will not
commence in connection with Executive’s termination of employment unless and until Executive has also incurred a
 “separation from service” (as such term is defined in Treasury Regulation Section 1.409A-1(h)), unless the Company
reasonably determines that such amounts may be provided to Executive without causing Executive to incur the additional 20% tax
pursuant to Section 409A. The parties intend that each installment of any series of payments provided for in this Agreement is a
separate “payment” for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). For the avoidance of doubt, the
parties intend that payments of the Separation Benefits set forth in this Agreement satisfy, to the greatest extent possible, the
exemptions from the application of Section 409A provided under Treasury Regulation Sections 1.409A-1(b)(4) and 1.409A-1(b)(9). If
the Company determines that the Separation Benefits constitute “deferred compensation” under Section 409A and Executive
is, on the termination of service, a “specified employee” of the Company or any successor entity thereto, as such term
is defined in Section 409A, then, solely to the extent necessary to avoid the incurrence of the adverse personal tax consequences
under Section 409A, the timing of the Separation Benefits payments will be delayed until the earlier to occur of: (i) the date that
is six months and one day after Executive’s separation from service, or (ii) the date of Executive’s death (such
applicable date, the “Specified Employee Initial Payment Date”), and the Company (or the successor entity
thereto, as applicable) will (A) pay to Executive a lump sum amount equal to the sum of the Separation Benefits payments that
Executive would otherwise have received through the Specified Employee Initial Payment Date if the commencement of the payment of
the Separation Benefits had not been so delayed pursuant to this Section and (B) commence paying the balance of the Separation
Benefits in accordance with the applicable payment schedules set forth in this Agreement.

 

		5.	Assignment
                                            and Binding Effect.

 

This Agreement will be binding
upon and inure to the benefit of Executive and Executive’s heirs, executors, personal representatives, assigns, administrators and
legal representatives. Because of the unique and personal nature of Executive’s duties under this Agreement, neither this Agreement
nor any rights or obligations under this Agreement will be assignable by Executive. This Agreement will be binding upon and inure to the
benefit of the Company and its successors, assigns and legal representatives. Any such successor of the Company will be deemed substituted
for the Company under the terms of this Agreement for all purposes. For this purpose, “successor” means any person, firm,
corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires all
or substantially all of the assets or business of the Company.

 

    9 

     

    

 

		6.	Notices.

 

Any notice required or
permitted to be given pursuant to this Agreement must be in writing and will be deemed effectively given to the other party (i) on
the date it is actually delivered by personal delivery of such notice in person, (ii) one business day after its deposit in the
custody of a reputable overnight courier service (such as FedEx) next business day delivery charges prepaid; or (iii) three business
days after its deposit in the custody of the U.S. mail, certified or registered postage prepaid, return receipt requested; in each
case to the appropriate address shown below (or to such other address as a party may designate by notice to the other party):

 

If to the Company:

 

Journey Medical Corporation

9237 E. Via de Ventura Blvd, Suite 105

Scottsdale, AZ 85258

Attn: Chief Executive Officer

 

If to Executive:

 

Ernest De Paolantonio

4733 Kensington Circle

Naples, FL 34119

 

		7.	Choice
                                            of Law.

 

This Agreement will be construed
and interpreted in accordance with the internal laws of the State of Delaware without regard to its conflict of laws principles.

 

		8.	Integration.

 

This Agreement, including the
PIIA and all other documents referenced herein, contains the complete, final and exclusive agreement of the Parties relating to the terms
and conditions of Executive’s employment and the termination of Executive’s employment, and supersedes all prior and contemporaneous
oral and written employment agreements or arrangements between the Parties.

 

		9.	Amendment.

 

This Agreement cannot be amended
or modified except by a written agreement signed by Executive and the Company.

 

		10.	Waiver.

 

No term, covenant or condition
of this Agreement or any breach thereof will be deemed waived, except with the written consent of the Party against whom the wavier is
claimed, and any waiver or any such term, covenant, condition or breach will not be deemed to be a waiver of any preceding or succeeding
breach of the same or any other term, covenant, condition or breach.

 

		11.	Severability.

 

The finding by a court of
competent jurisdiction of the unenforceability, invalidity or illegality of any provision of this Agreement will not render any
other provision of this Agreement unenforceable, invalid or illegal. Such court will have the authority to modify or replace the
invalid or unenforceable term or provision with a valid and enforceable term or provision, which most accurately represents the
Parties’ intention with respect to the invalid or unenforceable term, or provision.

 

    10 

     

    

 

		12.	Interpretation;
                                            Construction.

 

The headings set forth in this
Agreement are for convenience of reference only and will not be used in interpreting this Agreement. This Agreement has been drafted by
legal counsel representing the Company, but Executive has been encouraged to consult with, and has consulted with, Executive’s own
independent counsel and tax advisors with respect to the terms of this Agreement. The Parties acknowledge that each Party and its counsel
has reviewed and revised, or had an opportunity to review and revise, this Agreement, and any rule of construction to the effect that
any ambiguities are to be resolved against the drafting party will not be employed in the interpretation of this Agreement.

 

		13.	Attorneys
                                            Fees.

 

Except as otherwise prohibited
by law, in the event a Party brings an action to enforce the terms of this Agreement, in addition to any other remedies, the prevailing
party will be entitled to recovery of its reasonable attorneys’ fees and costs incurred by it arising out of such breach or the
defense thereof.

 

		14.	Representations
                                            and Warranties.

 

14.1               
Obligations to Prior Employers. Executive represents and warrants to the Company that Executive is not obligated or restricted
under any agreement (including any non-competition or confidentiality agreement), judgment, decree, order or other restraint of any kind
that could impair Executive’s ability to perform the duties and obligations required of Executive hereunder. Executive further represents
and warrants to the Company that he has not violated any confidentiality agreement or other similar obligation that he has to any former
employer and that he has not disclosed any confidential or trade secret information belonging to any former employer to the Company or
its agents. Executive agrees that he will not use confidential information and/or trade secrets belonging to any former employer in his
employment with the Company or otherwise as a resource for building the business of the Company and will structure his and the Company’s
work environment and practices in such a way to ensure that any such information will not be used or disclosed during the course of his
relationship with the Company.

 

14.2                Litigation
Support. Both during and after Executive’s employment with the Company, if the Company is evaluating, pursuing, contesting
or defending any proceeding, charge, complaint, claim, demand, notice, action, suit, litigation, hearing, audit, investigation,
arbitration or mediation, in each case whether initiated by or against the Company (collectively, a
 “Proceeding”), other than a Proceeding initiated by or against Executive, Executive will reasonably
cooperate with the Company and its counsel in the evaluation, pursuit, contest or defense of the Proceeding and provide such
testimony and access to books and records as may be necessary in connection therewith. Any such cooperation will be done at times
mutually convenient for Executive and the Company, and the Company will undertake reasonable efforts to minimize the interference
such cooperation may cause to any duties or obligations that Executive may have to a third party, including any future employer. The
Company will reimburse Executive for Executive’s reasonable out-of-pocket expenses related to such cooperation.

 

    11 

     

    

 

14.3               
Future Employment. In the event of Executive’s separation from the Company, regardless of the reason or cause of that
separation, Executive agrees that for a period of 12 months from the date his employment terminates, he will provide the Company with
no fewer than three business days’ notice of his intent to accept employment with or for an organization other than Company for
the express purpose of allowing the Company to determine if such proposed employment interferes with any of Executive’s surviving
obligations under this Agreement. The notice of intent to accept employment will identify the new employer, list Executive’s anticipated
title and describe his anticipated duties.

 

		15.	Counterparts.

 

This Agreement may be executed
in two counterparts, each of which will be deemed an original, all of which together will contribute one and the same instrument. Signatures
to this Agreement transmitted by fax, by email in “portable document format” (“.pdf”) or by any other electronic
means intended to preserve the original graphic and pictorial appearance of this Agreement will have the same effect as physical delivery
of the paper document bearing original signature.

 

		16.	Jurisdiction;
                                            Venue.

 

The Parties agree that any litigation
arising out of or related to this Agreement or Executive’s employment by the Company will be brought exclusively in any state or
federal court in New York, New York. Each Party (i) consents to the personal jurisdiction of said courts, (ii) waives any venue or inconvenient
forum defense to any proceeding maintained in such courts, and (iii) except as otherwise provided in this Agreement, agrees not to bring
any proceeding arising out of or relating to this Agreement or Executive’s employment by the Company in any other court.

 

		17.	Advertising
                                            Waiver.

 

Executive agrees to permit the
Company, and persons or other organizations authorized by the Company, to use, publish and distribute advertising or sales promotional
literature concerning the products and/or services of the Company, or the machinery and equipment used in the provision thereof, in which
Executive’s name and/or pictures of Executive taken in the course of Executive’s provision of services to the Company appear.
Executive hereby waives and releases any claim or right Executive may otherwise have arising out of such use, publication or distribution.

 

[Signature Page Immediately Follows]

 

    12 

     

    

 

In
Witness Whereof, the Company has caused this Agreement to be signed by its duly authorized officer and Executive has hereunto
set his hand and seal.

 

Journey
Medical Corporation

 

	CLAUDE MARAOUI	 	DATE
	PRESIDENT AND CEO	 	 

 

Executive:

 

	Ernest De Paolantonio	 	Date

 

    13 

     

    

 

EXHIBIT
A

 

Proprietary Information and Inventions Agreement

 

    14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]